14 employees
Proprietary in vitro, in vivo and patient ex-vivo platforms to address cancer metastasis drug discovery and predictive diagnostics
2018
$173K
from 2 investors over 2 rounds
Mestastop Solutions raised $173K on October 19, 2021
Investors: IKP KNOWLEDGE PARK and CIIE.CO